Author of the publication

copy delete add this publication to your clipboard
community post
history of this post
URL
DOI
BibTeX
EndNote
APA
Chicago
DIN 1505
Harvard
MSOffice XML

Fundamentally different roles of neuronal TNF receptors in CNS pathology: TNFR1 and IKKβ promote microglial responses and tissue injury in demyelination while TNFR2 protects against excitotoxicity in mice

I. Papazian, E. Tsoukala, A. Boutou, M. Karamita, K. Kambas, L. Iliopoulou, R. Fischer, R. Kontermann, M. Denis, G. Kollias, H. Lassmann, and L. Probert. Journal of neuroinflammation, 18 (1): 222--222 (September 2021)
DOI: 10.1186/s12974-021-02200-4

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Univ. -Prof. Dr. Roland Kontermann University of Stuttgart

E. Garrelts

E. Zafeiriou

Roland Weil University of Stuttgart

apl. Prof. Dr. Roland Gehrke University of Stuttgart

Other publications of authors with the same name

Superior Properties of Fc-comprising scTRAIL Fusion ProteinsM. Hutt, L. Marquardt, O. Seifert, M. Siegemund, I. Müller, D. Kulms, K. Pfizenmaier, and R. Kontermann. Molecular cancer therapeutics, 16 (12): 2792-2802 (2017)An optimized antibody-single-chain TRAIL fusion protein for cancer therapyM. Siegemund, O. Seifert, M. Zarani, T. Dzinic, V. De Leo, D. Göttsch, S. Münkel, M. Hutt, K. Pfizenmaier, and R. Kontermann. mAbs, 8 (5): 879-891 (2016)The making of bispecific antibodiesU. Brinkmann, and R. Kontermann. mAbs, 9 (2): 182-212 (2017)Systemic network analysis identifies XIAP and I kappa B alpha as potential drug targets in TRAIL resistant BRAF mutated melanomaG. Del Mistro, P. Lucarelli, I. Müller, S. De Landtsheer, A. Zinoveva, M. Hutt, M. Siegemund, R. Kontermann, S. Beissert, T. Sauter and 1 other author(s). NPJ systems biology and applications, (2018)Proteolysis-Targeting Chimeras Enhance T Cell Bispecific Antibody-Driven T Cell Activation and Effector Function through Increased MHC Class I Antigen Presentation in Cancer CellsV. Massafra, S. Tundo, A. Dietzig, A. Ducret, C. Jost, C. Klein, R. Kontermann, H. Knoetgen, M. Steegmaier, A. Romagnani and 1 other author(s). The journal of immunology, 209 (2): 493-504 (2021)Pharmacokinetic Engineering of OX40-Blocking Anticalin Proteins Using Monomeric Plasma Half-Life Extension DomainsM. Siegemund, P. Oak, E. Hansbauer, A. Allersdorfer, K. Utschick, A. Winter, C. Grasmüller, G. Galler, J. Mayer, B. Weiche and 3 other author(s). Frontiers in pharmacology, (2021)Corrigendum to "Bispecific antibodies" Drug Discov. Today 20 (July (7)) (2015) 838-847R. Kontermann, and U. Brinkmann. Drug Discovery Today, 24 (7): 1422 (2019)Correction to: https://doi.org/10.1016/j.drudis.2015.02.008.GlycoTAIL and FlexiTAIL as Half-Life Extension Modules for Recombinant Antibody FragmentsO. Seifert, and R. Kontermann. Molecules, 27 (10): 3272 (2022)Fc-based Duokines : dual-acting costimulatory molecules comprising TNFSF ligands in the single-chain format fused to a heterodimerizing Fc (scDk-Fc)N. Aschmoneit, K. Kocher, M. Siegemund, M. Lutz, L. Kühl, O. Seifert, and R. Kontermann. OncoImmunology, 11 (1): 2028961 (2022)Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activityI. Fernandez-Ulibarri, K. Hammer, M. Arndt, J. Kaufmann, D. Dorer, S. Engelhardt, R. Kontermann, J. Hess, H. Allgayer, J. Krauss and 1 other author(s). International journal of cancer, 136 (9): 2228-2240 (2015)

PUMA

Disambiguation of "Kontermann, Roland E"